Kaya Holdings (KAYS) Equity Average (2012 - 2025)
Kaya Holdings (KAYS) recorded quarterly Equity Average of -$12.0 million in Q3 2025, up 40.11% quarter-over-quarter from -$20.0 million in Q2 2025, and up 30.69% on a YoY basis from -$9.2 million in Q3 2024.
Kaya Holdings (KAYS) Equity Average (2012 - 2025) Analysis & Trends
Kaya Holdings' Equity Average history runs 13 years deep, the most recent figure standing at -$12.0 million for Q3 2025.
- In Q3 2025, Equity Average rose 30.69% year-over-year to -$12.0 million; the TTM figure through Sep 2025 stood at -$12.0 million (up 30.69% YoY), while the FY2024 annual figure was -$16.4 million, up 1.43% from the prior year.
- Equity Average was -$12.0 million for Q3 2025 at Kaya Holdings, up from -$20.0 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of -$12.0 million in Q3 2025 to a low of -$27.7 million in Q1 2021.
- Historically, Equity Average has averaged -$17.8 million across 5 years, with a median of -$17.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Equity Average jumped 45.93% in 2022, then decreased 27.2% in 2023.
- A 5-year view of Equity Average shows it stood at -$15.6 million in 2021, then slipped by 19.96% to -$18.7 million in 2022, then gained by 15.31% to -$15.9 million in 2023, then decreased by 11.19% to -$17.6 million in 2024, then jumped by 31.97% to -$12.0 million in 2025.
- The last three Equity Average figures came in at -$12.0 million (Q3 2025), -$20.0 million (Q2 2025), and -$18.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | -20.04 Mn |
| Mar 31, 2025 | -17.96 Mn |
| Dec 31, 2024 | -17.64 Mn |
| Sep 30, 2024 | -17.32 Mn |
| Jun 30, 2024 | -16.66 Mn |
| Mar 31, 2024 | -16.30 Mn |
| Dec 31, 2023 | -15.87 Mn |
| Sep 30, 2023 | -17.06 Mn |
| Jun 30, 2023 | -17.77 Mn |
| Mar 31, 2023 | -17.51 Mn |
| Dec 31, 2022 | -18.74 Mn |
| Sep 30, 2022 | -16.15 Mn |
| Jun 30, 2022 | -13.97 Mn |
| Mar 31, 2022 | -14.96 Mn |
| Dec 31, 2021 | -15.62 Mn |
| Sep 30, 2021 | -18.81 Mn |
| Jun 30, 2021 | -25.59 Mn |
| Mar 31, 2021 | -27.66 Mn |
| Dec 31, 2020 | -26.55 Mn |